Thermo Fisher Showcases Transformative Diagnostic Solutions

Thermo Fisher Scientific Inc. (Waltham, MA; USA) is showcasing its comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine, and further clinical research. Thermo Fisher is offering dynamic activities throughout the week, including more than 20 short lectures on various topics designed to help elevate laboratory performance and capabilities.

Visitors to Thermo Fisher’s booth at ADLM 2025 can experience its solutions firsthand during personalized product demonstrations and learn how the company’s diagnostics solutions help transform patient care. Visitors can also request tailored product demonstrations or schedule time to discuss solutions to help address their lab's needs. At ADLM 2025, Thermo Fisher is presenting new technologies and testing solutions that could enhance scientific results, boost operational efficiency, and advance clinical capabilities. Thermo Fisher is showcasing Aesku’s portfolio of FDA-cleared IFA products, automated instruments, like the Helios HTC, and software.

Thermo Fisher is also highlighting EliA assays, which help provide unparalleled focus on automation and workflow efficiency to support earlier diagnosis and improve care for patients with autoimmune conditions. Enabling faster and more accurate diagnoses for patients with complex autoimmune conditions, the Helios IFA System, together with the EliA portfolio, run on Phadia Laboratory Systems, meets the evolving needs of laboratories and allows for more efficient workflows by providing the most comprehensive suite of automated diagnostic systems and methodologies available in the U.S. market.

Binding Site, part of Thermo Fisher, is also participating in ADLM 2025, where it is showcasing its Optilite analyzer for special protein analysis that features an extensive assay menu for comprehensive testing options. The compact Optilite system features fully automated dilutions plus unrestricted access for samples and reagents, enabling a streamlined workflow for the entire laboratory. The Optilite system utilizes proven turbidimetric technology, which is known to be fast, robust, and versatile, becoming the main technology for protein diagnostics worldwide. Combining the Optilite system’s ease of use with Binding Site’s high-quality latex-enhanced assays gives peace of mind and the freedom to allocate time and resources in the most efficient way. Visitors can also experience Binding Site’s future innovative solution, the EXENT System, a mass spectrometry solution for M-protein assessment.

Related Links:
Thermo Fisher Scientific Inc.